01 4aripiprazole
02 1brexpiprazole
01 1OTSUKA PHARMACEUTICAL CO. LTD.
02 4OTSUKA PHARMACEUTICAL CO., LTD.
01 5Japan
NDC Package Code : 46602-0072
Start Marketing Date : 2014-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (400mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 46602-0045
Start Marketing Date : 2014-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (300mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 46602-0026
Start Marketing Date : 2012-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (400mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 46602-0025
Start Marketing Date : 2012-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (300mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 46602-0001
Start Marketing Date : 2015-07-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
